References
- Horowitz Z.P. Ed. Angiotensin Converting Enzyme Inhibitors. Mechanisms of Action and Clinical Implications. Urban & Schwarzenberg 1981
- Genest J., Kuchcl O., Hamet P., and Cantiti M. Eds. Hypertension. Physiopathology and Treatment. McGrawhill 1983
- Murphy M.B. Ed. Renin-Angiotensin-Aldosterone system: treatment of hypertension and heart failure. Hypertension (suppl 1) 1983
- Skeggs L.T., Kahn J.R., Shumway N.P. Preparation and function of the hypertensin-converting enzyme. J. Exp. Med. 103: 295–299 1956
- Bakhle Y.S. Conversion of angiotensin I to angiotensin II by cellfree extracts of dog lung. Nature 220: 919–921, 1968
- Ferreira S.H., Bailelt D.C., Greene L.J. Isolation of bradykinin-potentiating peptides from Bothrops jararacca venom. Biochemistry 9: 2583–2593, 1970
- Ondetti M.A., Rubin B., Cushman D.U. Design of specific inhibitions of angiotensin-converting enzyme. New class of orally active antihypertensive agents. Science 196:441–444, 1970
- Patchett A.A., Harris E., Tristram E.W., Wyvratt M.J., Wu M.T., Taub D., Peterson E.R., Ikeler T.J., tenBroeke J., Payne L.G., Ondeyka D.L., Thorsett E.D., Greenlee W.J., Lohr N.S., Hoffsommer R.D., Joshua H., Ruyle W.V., Rothrock J.W., Aster S.D., Maycock A.L., Robinson F.M., Hirschmann R., Sweet C.S., Ullm E.H., Gross D.M., Vassil T.C., Stone C.A. A new class of angiotensin-converting enzyme inhibitors. Nature 288: 280–283, 1980
- Aurell, M. Renal response in man to plasma volume expansion and angiotensin. Scand. J. Clin. Lab. Invest. 24(suppl 112), 1969
- Ljungman S., Aurell M., Hartford M., Wikstrand J., Berg-lund G. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure. Hypertension 5: 368–374, 1983
- Aurell M., Rudin A., Tisell L.-E., Kindblom L.-G., Sandberg G. Captopril effect on hypertension in a patient with a renin-producing tumor. Lancet ii: 149, 1979
- Aurell M., Rudin A., Kindblom L.-G, Tisell L.-E., Derkx F., Schalekamp M. A case of renin-producing non-renal tumour and the effect of treatment with captopril. Secondary forms of Hypertension. Current Diagnosis and Management. Blaufox and Bianchi. Eds P 179–186. Grune & Stratton, 1981
- Aurell M., and Rudin A. Effect of captopril on blood pressure, renal function, the electrolyte balance and the renin-angiotensin system in Bartter's Syndrome. Nephron. 33:274–278, 1983
- LaGrange Sloup C.H., Schmid H.E. Selective stimulation of renal nerves in anasthetized dog circulation research. Circ. Res. 33: 704–712, 1970
- Kopp U., Aurell M., Nilsson I.M., Åblad B. The role of beta I adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pfluegers Arch. 387: 107–113, 1980
- Ammons W.S., Koyama S., and Manning J.W. Neural and vascular interaction in renin response to graded renal nerve stimulation. Am. J. Physiol. 242: R552-R562, 1982
- Thorén P. Role of cardiac vagal C-fibers in cardiovascular control. Physiol. Biochem. Pharmacol. 86: 1–94 1979
- Bishop V.S., Malliani A., Thorén P. Cardiac mechanoreceptors. Handbook of Physiology, the cardiovascular system 3: 497–555, Williams and Wilkins, Baltimore 1983
- Henning M., and Johnsson G. Interference of phenoxy-benzamine and guanethidine with the vascoconstrictor responses of noradrenaline and angiotensin II in the hand. Acta Pharmacol. et toxicol. 25:373–384 1967
- Khairallah Ph.A. Pharmacology of Angiotensin. Kidney Hormones, 129–171, Academic Press London 1971.
- Starke K. The regulation of noradrenaline released by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77: 1–124, 1977
- Delin K., Aurell M., Granérus G. Preoperative diagnosis of renovascular hypertension. The use of acute stimulation of renin secretion. Acta Med. Scand. In press.